Aquinox Pharmaceuticals (AQXP) is a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer. Three other IPOs are scheduled for the
The full IPO calendar is available at IPOpremium. The scheduled IPOs are ranked by IPO size. (1) Based in Mountain View, CA, Coupons.com (COUP) scheduled a $130 million IPO on the NYSE with
HSBC Holdings PLC (HBC) said Tuesday that it reached a $1.9 billion settlement with U.S. state and federal authorities related to a money laundering investigation of the British bank. A deal
Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a regulator of a cellular signaling pathway in immune cells. The company's product candidate includes AQX-1125, which is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome, a chronic inflammatory disease of the bladder. All the business activity of the group is functioned through United States.
| Website: | www.aqxpharma.com |
| Email: | ir@aqxpharma.com |
| Main Phone: | +1 604 629-9223 |
| Address: | 450-887 Great Northern Way |
| Address 2: | Suite 450 |
| State: | BC |
| City / Town: | Vancouver |
| Country: | CAN |
| Postal Code: | V5T 4T5 |
| Exchange: | NSD |
| CEO: | David J. Main |
| Employees: | 8 |
| NAICS: | Pharmacies and Drug Stores(446110) |
Aquinox Pharmaceuticals (AQXP) is a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer. Three other IPOs are scheduled for the
The full IPO calendar is available at IPOpremium. The scheduled IPOs are ranked by IPO size. (1) Based in Mountain View, CA, Coupons.com (COUP) scheduled a $130 million IPO on the NYSE with
HSBC Holdings PLC (HBC) said Tuesday that it reached a $1.9 billion settlement with U.S. state and federal authorities related to a money laundering investigation of the British bank. A deal
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 2 |
| Number of Buys | 0 | 1 |
| Number of Sells | 0 | 1 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Julian C. Baker | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Lloyd Mackenzie | 1,000 |
| David J. Main | 1,000 |
| David J. Main | 1,000 |
| David J. Main | 1,000 |
| Lloyd Mackenzie | 1,000 |
| Kamran Alam | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 28 | 28 | 28 | 28 |
| Low Target Price Estimate | 26 | 26 | 26 | 26 |
| Mean Target Price Estimate | 27 | 27 | 27 | 27 |
| Standard Deviation | 1.41 | 1.41 | 1.41 | 1.41 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
